Dr. Partha Basu is a highly regarded expert in cancer prevention, with decades of experience in advancing innovative screening programs aimed at reducing the global cancer burden. His work at the International Agency for Research on Cancer (IARC) has been pivotal in improving early detection and developing cost-effective screening strategies, particularly in low- and middle-income countries where access to cancer care is limited.
Dr. Basu has played a significant role in designing and implementing screening initiatives that target cancers with high mortality rates in underserved regions. His efforts focus on making early detection more accessible, cost-efficient, and impactful, helping to identify cancers at a stage when treatment is more likely to be effective. By promoting and advancing these initiatives, Dr. Basu has been instrumental in improving cancer outcomes globally and reducing the healthcare disparities faced by many populations. His ongoing work continues to have a lasting impact on public health, particularly in areas where cancer prevention and detection resources are scarce.
Amal Al Omari
Amal Al Omari is a leading figure in cancer research and scientific leadership in the Middle East. As a prominent oncologist and researcher at the King Hussein Cancer Center (KHCC), she has been at the forefront of efforts to advance cancer treatment, research, and patient care not only in Jordan but across the entire Middle East region.
Her work has had a significant impact on improving cancer care in the region, where she has spearheaded initiatives aimed at enhancing early detection, treatment modalities, and patient outcomes. Her leadership has also helped KHCC become a regional hub for cancer research and innovation, collaborating with international institutions to drive forward the latest advancements in oncology. Dr. Al Omari’s contributions extend beyond clinical practice, as she continues to influence policy, advocate for better cancer care infrastructure, and lead groundbreaking projects that are improving the lives of cancer patients throughout the Middle East and beyond.
David Chapel
Dr. David Chapel is an Assistant Professor in the Department of Pathology at the University of Michigan, where he specializes in Women’s and Perinatal Pathology. He completed his fellowship at the renowned Brigham and Women’s Hospital in Boston, USA, gaining valuable expertise in the field. Dr. Chapel is dedicated to advancing diagnostic pathology, particularly in women’s health, by enhancing the accuracy and efficiency of diagnoses in perinatal and reproductive conditions.
His extensive experience and insights contribute significantly to both academic and clinical advancements in pathology. Dr. Chapel’s work is vital in improving patient care, particularly through better diagnostic methods and treatment strategies for women and perinatal patients. His contributions to the field of pathology position him as a respected figure in advancing medical knowledge and improving healthcare outcomes on a global scale.
Jennifer A. Harvey
Jennifer A. Harvey is a globally recognized expert in breast imaging and cancer detection. With a profound commitment to advancing radiology, she has made significant contributions to the development and enhancement of mammography techniques, ensuring more accurate and efficient breast cancer diagnosis. Her work focuses on improving early detection methods, ultimately leading to better outcomes for patients.
As a leader in the field, Jennifer A. Harvey has been instrumental in shaping the evolution of breast imaging, advocating for the integration of advanced technologies to refine diagnosis and treatment. Her efforts have helped to drive improvements in patient care, contributing to the early identification of breast cancer, which is crucial in improving survival rates and overall prognosis. Through her research and expertise, Harvey continues to push the boundaries of breast cancer detection and treatment.
Meteb Foheidi
Dr. Meteb Foheidi is a distinguished Breast Medical Oncologist and Associate Professor at King Abdul-Aziz Medical City in Saudi Arabia. With a wealth of expertise in oncology, he is renowned for his dedication to advancing cancer research, particularly in the field of breast cancer. His work focuses on improving cancer treatment outcomes and employing innovative approaches to patient care.
Dr. Foheidi has garnered recognition both nationally and internationally for his contributions to oncology. He is highly regarded for his commitment to enhancing the quality of life for cancer patients through personalized treatment strategies and cutting-edge research. As a respected leader in his field, Dr. Foheidi’s participation in this conference promises to offer valuable insights into the future of breast cancer care and global oncology advancements.
Omalkhair Abulkhair
Dr. Omalkhair Abulkair is a leading medical oncologist specializing in breast cancer and gynecologic malignancies. With a strong dedication to advancing cancer research and improving treatment outcomes, she has become a prominent figure in the medical oncology community. Her extensive experience spans both clinical care and cutting-edge research, focusing on enhancing patient care and developing innovative therapies for cancer treatment.
Dr. Abulkhair’s passion for patient-centered care is reflected in her approach to oncology, ensuring that each patient receives the most effective, personalized treatment possible. Her valuable insights and expertise, particularly in the areas of breast cancer and gynecologic malignancies, will significantly contribute to the discussions at the conference.
Sanaa Elsukhun
Prof. Sanaa Elsukhun is a renowned Professor of Medical Oncology at the University of Jordan, widely recognized for her extensive expertise in the field of oncology. With a career dedicated to advancing cancer research and improving treatment outcomes, Prof. Elsukhun has made significant contributions to the understanding and management of various cancers. Her work has had a lasting impact on cancer care, not only in Jordan but also on a global scale.
Prof. Elsukhun’s dedication to oncology research and clinical practice has led to numerous advancements in cancer treatment, with a particular focus on enhancing patient care through innovative therapies. As a respected leader in her field, her participation in the conference will bring invaluable insights into the latest developments in oncology, particularly in the context of improving cancer care and outcomes.
Simona Stolnicu
Prof. Simona Stolnicu is a leading authority in the field of pathology, currently serving as a Professor of Pathology at UMFST Targu Mures in Romania. With a career dedicated to advancing the field of cancer pathology, she has made significant contributions to the understanding of various cancer types, focusing on improving diagnostic techniques. Her extensive research has directly impacted the accuracy and efficiency of cancer diagnostics, enhancing clinical practices and treatment planning.
At this year’s conference, Prof. Stolnicu’s participation will offer attendees the opportunity to gain insights from her vast experience. Her pioneering research continues to drive advancements in cancer diagnosis and treatment. Prof. Stolnicu’s leadership and commitment to elevating the standards of oncology care globally highlight her as a critical figure in the oncology community, and her contributions are shaping the future of cancer pathology.
